SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lechner-Scott, J
Right arrow Articles by Gibberd, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lechner-Scott, J
Right arrow Articles by Gibberd, R
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Can the Expanded Disability Status Scale be assessed by telephone?

J Lechner-Scott

Department of Neurology, Kantonspital Basel, Switzerland, Department of Medicine, John Hunter Hospital, Newcastle, Australia

L Kappos

Department of Neurology, Kantonspital Basel, Switzerland, lkappos{at}uhbs.ch

M Hofman

Department of Neurology, Kantonspital Basel, Switzerland

C H Polman

Department of Neurology, University Hospital, Amsterdam, Netherlands

H Ronner

Department of Neurology, University Hospital, Amsterdam, Netherlands

X Montalban

Department of Neurology, Ciudad Sanitaria Vall d'Hebron, Barcelona, Spain

M Tintore

Department of Neurology, Ciudad Sanitaria Vall d'Hebron, Barcelona, Spain

M Frontoni

Clinica Neurologica de l'Università Rome, Rome, Italy

C Buttinelli

Clinica Neurologica de l'Università Rome, Rome, Italy

M P Amato

Department of Neurological and Psychiatric Sciences, University of Florence, Italy

M L Bartolozzi

Department of Neurological and Psychiatric Sciences, University of Florence, Italy

M Versavel

Klinische Entwicklung Schering, Germany

F Dahlke

Klinische Entwicklung Schering, Germany

J-F Kapp

Klinische Entwicklung Schering, Germany

R Gibberd

Department of Statistics, University of Newcastle, Newcastle, Australia

Information from patients who are unable to continue their visits to a study centre may be of major importance for the interpretatio n of results in multiple sclerosis (MS) clinical trials. To validate a questionnaire based on the Expanded Disability Status Scale (EDSS), patients in five different European centres were assessed independently by pairs of trained EDSS raters, first by telepho ne interview and a few days later by standardized neurological examination. Seventy women and 40 men with an average age of 43.7 years (range 19 -74 years) were included in the study. Mean EDSS score at the last visit was 4.5 (0 -9). EDSS assessment by telepho ne was highly correlated with the EDSS determined by physical examination (Pearson’s correlation coefficient -0.95). A n intraclass correlation coefficient (IC C) of 94.8% was found for the total sample; 77.6% and 86%, respectively, for patients with EDSSB-4.5 (n -46) and \-4.5 (n -64). Kappa values for full agreement were 0.48; for variation by -0.5 steps and -1.0 steps, 0.79 and 0.90, respectively. Best agreement could be found in higher EDSS scores, where assessment by telepho ne interview might be needed most. The telepho ne questionnaire is a valid tool to assess EDSS score in cases where the patient is unable to continue visiting a study centre or in long-term follow-up of trial participants.

Key Words: assessment • clinical scale • multiple sclerosis

Multiple Sclerosis, Vol. 9, No. 2, 154-159 (2003)
DOI: 10.1191/1352458503ms884oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BMJHome page
M. Boggild, J. Palace, P. Barton, Y. Ben-Shlomo, T. Bregenzer, C. Dobson, and R. Gray
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator
BMJ, December 2, 2009; 339(dec02_1): b4677 - b4677.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
A Minneboo, B. Uitdehaag, P Jongen, H Vrenken, D. Knol, M. van Walderveen, C. Polman, J. Castelijns, and F Barkhof
Association between MRI parameters and the MS severity scale: a 12 year follow-up study
Multiple Sclerosis, May 1, 2009; 15(5): 632 - 637.
[Abstract] [PDF]


Home page
BrainHome page
E. C. Tallantyre, L. Bo, O. Al-Rawashdeh, T. Owens, C. H. Polman, J. Lowe, and N. Evangelou
Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
Brain, May 1, 2009; 132(5): 1190 - 1199.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. K. Swanton, K. T. Fernando, C. M. Dalton, K. A. Miszkiel, D. R. Altmann, G. T. Plant, A. J. Thompson, and D. H. Miller
Early MRI in optic neuritis: The risk for disability
Neurology, February 10, 2009; 72(6): 542 - 550.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L Costelloe, A Thompson, C Walsh, N Tubridy, and M Hutchinson
Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease
J. Neurol. Neurosurg. Psychiatry, November 1, 2008; 79(11): 1245 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
Z. Khaleeli, D. R. Altmann, M. Cercignani, O. Ciccarelli, D. H. Miller, and A. J. Thompson
Magnetization Transfer Ratio in Gray Matter: A Potential Surrogate Marker for Progression in Early Primary Progressive Multiple Sclerosis
Arch Neurol, November 1, 2008; 65(11): 1454 - 1459.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. K. Fisniku, P. A. Brex, D. R. Altmann, K. A. Miszkiel, C. E. Benton, R. Lanyon, A. J. Thompson, and D. H. Miller
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
Brain, March 1, 2008; 131(3): 808 - 817.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R.A. Marrie and M. Goldman
Validity of performance scales for disability assessment in multiple sclerosis
Multiple Sclerosis, November 1, 2007; 13(9): 1176 - 1182.
[Abstract] [PDF]


Home page
Mult SclerHome page
L Lopatinskaya, J Zwemmer, B Uitdehaag, K Lucas, C Polman, and L Nagelkerken
Mediators of apoptosis Fas and FasL predict disability progression in multiple sclerosis over a period of 10 years
Multiple Sclerosis, November 1, 2006; 12(6): 704 - 709.
[Abstract] [PDF]


Home page
BrainHome page
F. Agosta, M. Rovaris, E. Pagani, M. P. Sormani, G. Comi, and M. Filippi
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis
Brain, October 1, 2006; 129(10): 2620 - 2627.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Kappos, A. Traboulsee, C. Constantinescu, J. -P. Eralinna, F. Forrestal, P. Jongen, J. Pollard, M. Sandberg-Wollheim, C. Sindic, B. Stubinski, et al.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Neurology, September 26, 2006; 67(6): 944 - 953.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S J Pittock, R L McClelland, S J Achenbach, F Konig, A Bitsch, W Bruck, H Lassmann, J E Parisi, B W Scheithauer, M Rodriguez, et al.
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease
J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1693 - 1697.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A.J. Visschedijk, B. M.J. Uitdehaag, M. Klein, E. van der Ploeg, E. H. Collette, L. Vleugels, L. E.M.A. Pfennings, E. L.J. Hoogervorst, H. M. van der Ploeg, and C. H. Polman
Value of health-related quality of life to predict disability course in multiple sclerosis
Neurology, December 14, 2004; 63(11): 2046 - 2050.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. J. Pittock, W. T. Mayr, R. L. McClelland, N. W. Jorgensen, S. D. Weigand, J. H. Noseworthy, and M. Rodriguez
Disability profile of MS did not change over 10 years in a population-based prevalence cohort
Neurology, February 24, 2004; 62(4): 601 - 606.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. T. Ingle, V. L. Stevenson, D. H. Miller, and A. J. Thompson
Primary progressive multiple sclerosis: a 5-year clinical and MR study
Brain, November 1, 2003; 126(11): 2528 - 2536.
[Abstract] [Full Text] [PDF]



Advertisement